I've been mapping the completed retatrutide CTgov entries and hit a wall. NCT05931367 enrolled 445 in obesity/overweight plus knee OA, NCT05548231 had 32 Chinese participants, NCT06039826 had 46 postmenopausal women. All completed, but I can't find topline weight or lab results.
Meanwhile Phase 2 showed 24.2% at 48 weeks and company Phase 3 reports up to 28.7%, not peer-reviewed. Why would completed trials stay quiet while those numbers circulate? Am I missing registry updates, conference abstracts, or is this normal lag?